Skip to main content
Table of Contents
Print

How do copy number variations influence autism susceptibility? 

Author: Hannah Smith, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Copy number variations and autism are closely linked, as changes in the number of copies of certain genes can influence the likelihood of developing autism spectrum disorder (ASD). CNVs, which refer to deletions or duplications of sections of DNA, can have a significant impact on brain development and function, contributing to autism susceptibility. These copy number variations and autism are thought to affect the gene dosage of key genes involved in neurodevelopment, disrupting normal synaptic function and neuronal communication. 

Research into copy number variations and autism has shown that alterations in gene dosage can lead to significant changes in neurodevelopmental impact, influencing how the brain forms and functions. In some cases, duplications or deletions in DNA regions can increase the risk of autism by disrupting genes that regulate neural growth, social behaviour, and communication. Understanding how CNVs contribute to autism susceptibility is crucial for developing personalised diagnostic and therapeutic strategies. 

The Role of Copy Number Variations in Autism Susceptibility 

Exploring how copy number variations and autism are linked helps provide a deeper understanding of the genetic factors that contribute to autism development. 

Gene Dosage and Autism Symptoms 

The number of copies of a gene present, can influence the expression of autism traits. Both deletions and duplications of genes have been shown to disrupt brain circuits involved in social interaction, sensory processing, and learning. 

Neurodevelopmental Impact of CNVs  

The neurodevelopmental impact of CNVs can lead to differences in brain structure and connectivity, resulting in the behavioural and cognitive traits commonly observed in autism. 

Visit providers like Autism Detect for expert, personalised consultations. They can help interpret genetic findings and suggest targeted support strategies. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Gene Mutations and Chromosomal Variations.  

Hannah Smith, MSc
Author

Hannah Smith is a clinical psychologist with a Master’s in Clinical Psychology and over three years of experience in behaviour therapy, special education, and inclusive practices. She specialises in Applied Behavior Analysis (ABA), Cognitive Behavioural Therapy (CBT), and inclusive education strategies. Hannah has worked extensively with children and adults with Autism Spectrum Disorder (ASD), ADHD, Down syndrome, and intellectual disabilities, delivering evidence-based interventions to support development, mental health, and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories